Same thing last night, sweated but not as much as three nights ago... Seems like this is just going to become the norm.
We had breakfast and then went outside - it was a gorgeous day today. AJ walked around outside and then parked himself front row to watch me wash our cars. FYI he is a great back seat driver when it comes to car washes!
"If it was me, I would rinse a little before I soap the other side. I would move the car a little bit more in the shade, but again that is just if it was me"
Hahahhaha! He's cute :)
Either way my way or his way, the cars are clean and shining!
Not a whole lot to report today - we spend a few hours outside and it seems like he is a little bit more energetic today. Not running around but just moving inside and chatting and making pop corn :)
I wish he could have the PICC line out, seems like it bothers him a lot. Annoying for him to feel it inside. also he has just never done well with anything medical, since he has always been so healthy. So every time he feels it, it reminds him of that something is inside him that shouldn't be there. (that is what I think, he didn't say it)
So tomorrow is the 'big' day at MD Anderson...
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...